Oncternal Therapeutics (NASDAQ:ONCT) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a report issued on Monday. The brokerage issued a sell rating on the stock. Several other research firms also recently weighed in on ONCT. HC Wainwright upgraded shares of Oncternal Therapeutics from a neutral rating to a buy rating and set a […]

Related Keywords

,Cantor Fitzgerald ,Richmond Brothers Inc ,Oncternal Therapeutics Inc ,Goldman Sachs Group Inc ,Oncternal Therapeutics Company Profile ,Oncternal Therapeutics ,Free Report ,Therapeutics Trading Down ,Get Free Report ,Sigma Investments ,Sigma Advisers ,Sachs Group ,Orphan Receptor ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,